MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,848 Cr | ₹3,240 Cr | ₹2,681 Cr | ₹2,190 Cr | ₹1,660 Cr |
What is the latest Total Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹3,848 Cr |
| Mar2025 | ₹3,240 Cr |
| Mar2024 | ₹2,681 Cr |
| Mar2023 | ₹2,190 Cr |
| Mar2022 | ₹1,660 Cr |
How is Total Liabilities of MARKSANS PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,848 Cr | 18.78 | |
| Mar2025 | ₹3,240 Cr | 20.84 | |
| Mar2024 | ₹2,681 Cr | 22.40 | |
| Mar2023 | ₹2,190 Cr | 31.94 | |
| Mar2022 | ₹1,660 Cr | - | |
Compare Total Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹13,897.4 Cr | 3.4% | -10.6% | 78.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 3.4% |
-10.6% |
78.1% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses